Thompson Tamar 4
4 · Avidity Biosciences, Inc. · Filed Oct 9, 2024
Insider Transaction Report
Form 4
Thompson Tamar
Director
Transactions
- Exercise/Conversion
Common Stock
2024-10-07$27.63/sh+30,000$828,900→ 30,000 total - Sale
Common Stock
2024-10-07$44.98/sh−30,000$1,349,259→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-07−30,000→ 0 totalExercise: $27.63Exp: 2031-01-10→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $44.20 to $45.57. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The option was granted on January 11, 2021 and fully vested prior to the date of transactions described in this form.